Abstract:Studies analyzing human cancer genome sequences and genetically modified mouse models have extensively expanded our understanding of human tumorigenesis, even challenging or reversing the dogma of certain genes as originally characterized by in vitro studies. Inhibitor-κB kinase α (IKKα), which is encoded by the conserved helix-loop-helix ubiquitous kinase (CHUK) gene, is first identified as a serine/threonine protein kinase in the inhibitor-κB kinase complex (IKK), which is composed of IKKα, IKKβ, and IKKγ (NEMO). IKK phosphorylates serine residues 32 and 36 of IκBα, a nuclear factor-κB (NF-κB) inhibitor, to induce IκBα protein degradation, resulting in the nuclear translocation of NF-κB dimers that function as transcriptional factors to regulate immunity, infection, lymphoid organ/cell development, cell death/growth, and tumorigenesis. NF-κB and IKK are broadly and differentially expressed in the cells of our body. For a long time, the idea that the IKK complex acts as a direct upstream activator of NF-κB in carcinogenesis has been predominately accepted in the field. Surprisingly, IKKα has emerged as a novel suppressor for skin, lung, esophageal, and nasopharyngeal squamous cell carcinoma, as well as lung and pancreatic adenocarcinoma (ADC). Thus, Ikkα loss is a tumor driver in mice. On the other hand, lacking the RANKL/RANK/IKKα pathway impairs mammary gland development and attenuates oncogene- and chemical carcinogen-induced breast and prostate tumorigenesis and metastasis. In general, NF-κB activation leads one of the major inflammatory pathways and stimulates tumorigenesis. Since IKKα and NF-κB play significant roles in human health, revealing the interplay between them greatly benefits the diagnosis, treatment, and prevention of human cancer. In this review, we discuss the intriguing attribution of NF-κB to CHUK/IKKα-involved carcinogenesis.

Role of IKK-NFκB Signaling Pathway in Inflammation and Tumorigenesis

NF-κB, inflammation, immunity and cancer: coming of age

From Inflammation to Cancer: the Molecular Basis

NF‐κB signaling in inflammation and cancer

Inflammation meets cancer, with NF-κB as the matchmaker

Attribution of NF-κB Activity to CHUK/IKKα-Involved Carcinogenesis

Dysregulation of mTOR pathway by IKKβ links inflammation and tumor angiogenesis

PKB/Akt-dependent regulation of inflammation in cancer

Inflammation and tumor progression: signaling pathways and targeted intervention

Inflammation-Induced Tumorigenesis and Metastasis

Role of Interleukins in Inflammation-Mediated Tumor Immune Microenvironment Modulation in Colorectal Cancer Pathogenesis

The NF-κB Signaling Pathway, the Microbiota, and Gastrointestinal Tumorigenesis: Recent Advances

The Role of Toll-Like Receptor in Inflammation and Tumor Immunity

Tumor-Elicited Inflammation and Colorectal Cancer

IKKβ Suppression of TSC1 Links Inflammation and Tumor Angiogenesis Via the Mtor Pathway

Versatile function of NF-ĸB in inflammation and cancer

Inflammation-Induced Tumorigenesis: Diminished Noncanonical NF-κB Signaling is Associated with Pathogenesis of Colitis-associated Colorectal Cancer

Effects of immune cells and cytokines on inflammation and immunosuppression in the tumor microenvironment

Inflammasomes and Cancer: The Dynamic Role of the Inflammasome in Tumor Development

Dynamic roles of inflammasomes in inflammatory tumor microenvironment

The complexity of NF-κB signaling in inflammation and cancer